10x Insights
Loading account…
Companies / Consumer Discretionary / ASHLAND INC.
ASH

ASHLAND INC.

Consumer DiscretionaryWholesale
Ticker ASHWILMINGTON, DEFiscal year ends SeptemberBook value per share $29.68Diluted shares 63.0M

Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company headquartered in Wilmington, Delaware, with operations spanning more than 100 countries. The company maintains its corporate website at www.ashland.com and employs approximately 2,900 people worldwide across manufacturing, research, and… From the company’s description.

Fiscal year 2025 · ends 09-30Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$1.82B
−13.7% year over year
Last 12 mo $1.84B
-42.49%
−41.3 percentage points
Last 12 mo 7.44%
$-845.00M
−600.0% year over year
Last 12 mo $52.00M
-8.81%
−14.7 percentage points
Last 12 mo 2.78%
Cash & financing
$134.00M
−71.0% year over year
Last 12 mo $335.00M
$36.00M
−88.9% year over year
Last 12 mo $250.00M
0.93
Was 0.61× a year earlier
Last 12 mo 0.95
—

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What ASHLAND INC. does

In the company’s own words

Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company headquartered in Wilmington, Delaware, with operations spanning more than 100 countries. The company maintains its corporate website at www.ashland.com and employs approximately 2,900 people worldwide across manufacturing, research, and distribution facilities.

The company operates through four primary reportable segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences, representing 39 percent of total consolidated sales, supplies excipients and tablet coating systems to pharmaceutical and nutrition industries, with core products including cellulosics and vinyl pyrrolidone polymers used in oral solid dosage formulations and functional food applications. Personal Care, also representing a significant portion of revenues, develops biofunctionals, preservatives, and specialty polymers for skin care, hair care, oral care, and household cleaning applications. Specialty Additives, the largest segment at 62 percent of sales within that division, provides rheology modifiers and performance-enhancing additives for architectural coatings, construction, energy, and automotive markets. Intermediates manufactures 1,4 butanediol and related derivatives used as chemical intermediates and specialty solvents across multiple industries.

Ashland's product portfolio includes cellulosics and polyvinylpyrrolidones, which collectively represent 25 percent of total consolidated sales. The company maintains eleven manufacturing and laboratory facilities across Life Sciences operations in nine countries, nine facilities for Personal Care in ten countries, and eight facilities for Specialty Additives across eight countries. Intermediates operates a primary manufacturing facility in Lima, Ohio, with derivative production at additional locations.

The company serves diverse end markets including architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical sectors. Ashland competes on product performance, quality, pricing, supply security, technical capability, and customer service. The company maintains a broad intellectual property portfolio including patents, trademarks, trade secrets, and proprietary formulations that differentiate its product offerings in highly fragmented global markets. In August 2024, Ashland divested its nutraceuticals business, reflecting its strategic focus on core specialty ingredients and additives operations.

Company details
Sector
Consumer Discretionary
Industry
Wholesale
Headquarters
WILMINGTON, DE
Fiscal year end
September
CIK
1674862
SIC
5160

Financial performance, year by year

Fiscal 2013–2025 · USD
$-1.71B$886.60M$3.48B$6.08B$8.68B2013201420152016201720182019202020212022202320242025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns ASHLAND INC. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

301
funds hold it
0 of 35
superinvestors hold it
$1.36B
held by funds, at market
48.1%
of shares held by funds
2
bond issues held by funds

Largest fund holders · ASHLAND INC.’s weight in each

iShares Core S&P Mid-Cap ETF
IJH · iShares Trust
0.08%of fund net assets
VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
MFS Mid Cap Value Fund
MVCAX · MFS SERIES TRUST XI
0.49%of fund net assets
iShares Russell 2000 ETF
IWM · iShares Trust
0.10%of fund net assets
VANGUARD SMALL-CAP INDEX FUND
VB · VANGUARD INDEX FUNDS
0.04%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

ASHLAND INC.’s bonds, as funds hold them

Funds report holding 2 issues of ASHLAND INC.’s debt, $179.63M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 4.99%, maturing 2031 to 2043.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do ASHLAND INC. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of ASHLAND INC.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in ASHLAND INC.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.